The Effect of Anemia on Retinopathy of Prematurity in Extremely Low Birth Weight Infants 1
|
|
- Oswald Cameron
- 6 years ago
- Views:
Transcription
1 The Effect of Anemia on Retinopathy of Prematurity in Extremely Low Birth Weight Infants 1 Judith A. Englert, MD Richard A. Saunders, MD Dilip Purohit, MD Thomas C. Hulsey, MSPH, SCD Myla Ebeling OBJECTIVE: Numerous risk factors for development of retinopathy of prematurity (ROP)in very low birth weight infants have been identified in the literature. However, the role of anemia in the development of ROP has not been adequately addressed. STUDY DESIGN: We retrospectively examined the medical records of all infants weighing 800 g who were admitted to a university hospital between July 1, 1992 and December 30, Highest and lowest hemoglobin and hematocrit values and the number of blood transfusions were recorded at each week of life during hospitalization. Gestational age at birth, birth weight, race, sex, oxygen status, history of bronchopulmonary dysplasia, length of hospital stay, and sepsis were also identified as potential risk factors. Data were analyzed using logistic regression to adjust for these confounding variables. RESULTS: Infants were grouped according to ROP status in the following manner: stage 0 to 1 ROP, stage 2 ROP, and stage 3 to threshold ROP. Sex, gestational age at birth, bronchopulmonary dysplasia, ventilator days, length of hospital stay, and number of blood transfusions were significantly associated with severity of ROP by univariate analysis. Using a logistic regression model, only gestational age ( p =0.007)and number of blood transfusions ( p=0.04) remained statistically significant. CONCLUSIONS: Anemia did not affect severity of ROP as an independent risk factor. However, the number of blood transfusions did affect the highest stage of ROP in this group of premature infants. Infants who remained severely anemic (Hgb8 g/dl or Hct25%)for longer periods of time developed milder ROP than less anemic infants. Journal of Perinatology 2001; 21:21± 26. INTRODUCTION Retinopathy of prematurity (ROP)has become increasingly prevalent worldwide as more very low birth weight infants are surviving the neonatal period and remains a major cause of visual morbidity among these children. 1±3 In 1979, Phelps 4 estimated that 163 infants per million live births were blinded because of ROP. More recently, in 1990, Brown et al. 5 estimated that number to have nearly doubled to 301 per million live births, presumably due to the increased survival rate of infants weighing <1000 g at birth. In the United States, ROP is the second leading cause of childhood blindness, following only cortical visual impairment. 6 Numerous retrospective studies have examined potential risk factors contributing to development of ROP. These have included low gestational age at birth, 7±12 low birth weight, 5,10,12 ± 14 male sex, 9 white race, 12,15 bronchopulmonary dysplasia, 5,10,13,16 sepsis, 8,13 acidosis, 7,11,16 oxygen therapy, 14,17 hyperoxia, 2,11,18 hypocarbia, 19 hypoxia, 1,11,19 and maternal use of beta blockers immediately before birth. 14 Recently, a case of neonatal HIV infection after blood transfusion at another institution led to a decrease in blood transfusions in premature infants at that hospital. Many lower risk infants went on to develop severe ROP, raising the concern that this change in transfusion practice and resultant anemia might be etiologically important ( J. O'Neil, personal communication, April, 1998). A subsequent review of the literature revealed that very few studies addressed the effect of anemia on incidence or severity of ROP. Bossi et al. 7 found no association between hemoglobin levels and development of ROP, but did identify a greater frequency of blood transfusions in infants who developed ROP using univariate analysis. A recent report by Brooks et al. 20 showed no difference in ROP incidence or severity between infants receiving blood transfusions to maintain high hematocrit levels (40%)and infants receiving blood transfusions only when clinically symptomatic. Other reports have not addressed anemia specifically. However, they did suggest that frequency of blood transfusions may be a risk factor in the development of ROP in infants weighing less than 1500 g, although this correlation was not substantiated using logistic regression. 8,19,21 We present our findings in evaluating the role of anemia and blood transfusions in the development of ROP in extremely low birth weight infants. N. Edgar Miles Center for Pediatric Ophthalmology ( J.A.E., R.A.S. ), Storm Eye Institute, Medical University of South Carolina, Charleston, SC; Department of Pediatrics ( D.P., T.C.H., M.E. ), Medical University of South Carolina, Charleston, SC. 1 This study was supported in part by an unrestricted grant to the Storm Eye Institute from Research to Prevent Blindness, Inc., New York, NY. Address correspondence and reprint requests to Richard A. Saunders, MD, Storm Eye Institute, 171 Ashley Avenue, Charleston, SC Journal of Perinatology 2001; 21:21 ± 26 # 2001 Nature Publishing Group All rights reserved /01 $17 PATIENTS AND METHODS We retrospectively reviewed the inpatient medical records of infants weighing 800 g admitted to the Neonatal Intensive Care Unit of a university hospital between July 1, 1992, and December 30, 1997, to determine whether the frequency of anemia or blood 21
2 Englert et al. Anemia and ROP Table 1 Demographics of Infant Groups Based on Severity of ROP Stage 1 Stage 2 Stage 3 p Value No. (%)(n=23)no. (%)(n=41)no. (%)(n=23) Sex 0.03 male (n=39)6 (15) 18 (46) 15 (38) female (n=48)17 (35) 23 (48) 8 (17) Race 0.14 black (n=60)13 (22) 32 (53) 15 (25) white (n=27)10 (37) 9 (33) 8 (30) EGA (weeks) 0.14 mean SD median (range)27 (24±31) 25 (23±28) 24 (23±28) Birth weight (g) 0.12 mean SD median (range)715 (508±792)723 (510±795)686 (514±800) EGA, estimated gestational age. transfusion influenced the severity of ROP. This study was considered exempt from informed consent by the Institutional Review Board for Human Research, and hence informed consent was not obtained. A total of 292 infants meeting our criteria were identified. One hundred seventy infants died before hospital discharge and were excluded from data analysis due to the inability to determine final ROP outcome. Of the remaining 122 surviving infants, inadequate documentation of anemia status or ROP status resulted in exclusion of an additional 35 infants, leaving the medical records of 87 infants suitable for evaluation. Patient demographics are shown in Table 1. Approximately two-thirds of the infants were identified as black and the remainder white. There were more females than males in the group (48 vs. 39, p=0.14). Birth weights of the infants ranged from 508 to 800 g, and estimated gestational age (EGA)at birth ranged from 23 to 31 weeks. Highest and lowest hemoglobin and hematocrit levels as well as total number of blood transfusions received were documented for each week of life during hospitalization. The frequency of anemia was evaluated, with anemia defined as hemoglobin 10 g/dl or hematocrit 30%. The frequency of severe anemia, defined as hemoglobin 8 g/dl and hematocrit 25%, was also evaluated. Due to the likelihood that factors other than the patient's hemoglobin or hematocrit levels, such as pulmonary disease and oxygen therapy, were utilized in the decision to perform blood transfusions, other potential confounding variables were also analyzed. These factors were bronchopulmonary dysplasia, sepsis, ventilator days, number of days of oxygen, and length of hospital stay. When required, a standard volume of replacement blood transfusion consisting of 15 ml/kg of packed red blood cells was given in all cases. Exchange transfusions, which are used to treat hyperbilirubinemia, were excluded from data analysis because elevated serum bilirubin levels, rather than anemia status, was the basis for the decision to initiate transfusion. In addition, the outcome of each ROP examination was recorded. The most severe stage of ROP that developed in the right eye of each infant was used for data analysis. However, in all but one infant, the same level of ROP severity was present in each eye. Data were evaluated using analysis of variance and logistic regression. Infants were grouped according to the highest stage of ROP reached. Due to the small number of patients reaching each stage of ROP, subgroups were combined into groups based on clinical severity and risk for adverse visual outcome: stage 1, stage 2, and stage 3 (including threshold). 22 Variables were cross-tabulated with each ROP group, and differences between the three groups were tested using chi-square for categorical variables and analysis of variance of means for continuous variables. Logistic regression was Figure 1. Eighty- seven premature infants with birth weight 508 to 800 g were grouped according to severity of ROP: Stage 1 (n=23), stage 2 (n=41), and stage 3 (including threshold, n=23). Infants with more severe ROP were more likely to have received multiple blood transfusions ( p= 0.04). Error bars represent standard deviation. 22 Journal of Perinatology 2001; 21:21 ± 26
3 Anemia and ROP Englert et al. Table 2 Infant Characteristics That Potentially Affected the Decision to Transfuse Blood and Their Relationship to Severity of ROP Stage 1 Stage 2 Stage 3 p Value No. (%)(n=23)no. (%)(n=41)no. (%)(n=23) Bronchopulmonary dysplasia present (n=73)14 (19)37 (51)22 (30) absent (n=14)9(64)4(29)1(7) Sepsis 0.46 present (n=55)14 (25)24 (44)17 (31) absent (n=32)9 (28)17 (53)6 (19) Ventilator assistance ( days) mean SD median (range)18 (0±65)32.5 (0±286)45 (0±62) Supplemental oxygen ( days) 0.12 mean SD median (range)39 (0±126)53.5 (0±287)50 (0±119) Length of hospital stay (days) 0.01 mean SD median (range)80 (26±121)89 (11±533)100 (25±134) Total number of transfusions mean SD median (range)4 (1±13)8.5 (0±20)10 (1±19) Number weeks Hct 30% or Hgb 10 g/dl 0.31 mean SD median (range)6 (2±11)6 (1±12)7 (1±11) Hct, hematocrit; Hgb, hemoglobin. used to examine the association between total number of transfusions, anemia, and severity of ROP controlling for potential confounding variables. To increase the power of the logistic regression, infants with stage 2 ROP and infants with stage 3 to threshold ROP were combined into one group as a dichotomous variable. These two groups were combined because analysis of variance statistics revealed no differences in the characteristics of these groups. Infants with stage 0 to 1 ROP remained the second dichotomous variable for analysis. RESULTS The characteristics of each group based on ROP severity are shown in Table 1. Male infants were more likely to progress to more severe ROP ( p=0.03). Although other reports have indicated that white infants tend to develop worse disease, 12,15 we did not identify race as a significant predictor of ROP severity ( p=0.14). As expected, EGA at birth was strongly correlated with severity of ROP ( p=0.0001), with the more premature infants developing more severe disease. However, birth weight was not correlated with ROP severity, perhaps because the range of birth weights in our study group was narrow (508 to 800 g). Next, other possible risk factors for development of ROP were evaluated. Infants who received a greater number of blood transfusions developed more severe ROP ( p=0.0007)(figure 1). Only one patient in this study did not receive transfused blood, a white female infant with birth weight of 766 g and EGA of 27 weeks who developed stage 2 ROP. There were no identifiable trends regarding infant age at the time of blood transfusion and severity of ROP. However, the decision to transfuse was not determined solely by hemoglobin/hematocrit levels but also by respiratory rate and effort, ventilator/oxygen status, sepsis, and overall health of the infant. The association of these potential confounding variables with the development of ROP is shown in Table 2. Bronchopulmonary Table 3 Potential Risk Factors for Severity of ROP Using Logistic Regression p Value Sex 0.10 Race 0.72 Estimated gestational age at birth Birth weight 0.89 Bronchopulmonary dysplasia 0.32 Days on ventilator 0.60 Days receiving supplemental oxygen 0.59 Length of hospital stay 0.53 Anemia (number of weeks Hct 30% or Hgb 10 g/dl)0.17 Total number of blood transfusions 0.04 Hct, hematocrit; Hgb, hemoglobin. Journal of Perinatology 2001; 21:21 ± 26 23
4 Englert et al. Anemia and ROP Table 4 Relationship of Severe Anemia to Highest Stage of ROP Observed Stage 1 Stage 2 Stage 3 p Value ( univariate analysis) p Value ( logistic regression) Number of weeks of severe anemia mean SD median (range)3 (0±6)1 (0±6)2 (0±6) Mean number of transfusions Severe anemia is defined as hematocrit 25% or hemoglobin 8 g/dl. dysplasia was significantly associated with ROP severity ( p=0.001). More severe ROP was also associated with a greater number of ventilator days ( p=0.004)and longer hospital stays ( p=0.01). A possible correlation between anemia and severity of ROP was also evaluated. All babies developed anemia at some time during their hospitalization, with anemia being defined as hemoglobin 10 g/dl or hematocrit 30% in this study. The mean lowest hemoglobin and hematocrit level for each week of life was similar for all groups, with lowest levels occurring between 5 and 6.5 weeks of age. There was no correlation between the frequency of anemia and ROP severity (Table 2). Maximum hemoglobin and hematocrit levels for each week of life were also similar for all groups and did not appear to affect the development of ROP. Logistic regression showed only two characteristics that remained statistically significant when controlling for potential confounding variables: EGA at birth ( p=0.007)and total number of transfusions ( p=0.04)in these extremely low birth weight infants (Table 3). The relationship between the duration of severe anemia (hemoglobin 8 g/dl or hematocrit 25%)and the development of ROP was then analyzed. Infants who were severely anemic for longer periods of time and received fewer transfusions developed milder ROP (stage 0 to 1)than infants who were severely anemic for shorter periods of time and received more transfusions (ROP stage 2 or greater)(table 4). Logistic regression analysis showed that severe anemia was significantly associated with ROP severity ( p=0.03). However, the number of transfusions no longer remained a significant risk factor ( p=0.12), indicating that these two variables were highly codependent. Our sample size was too small to determine whether delaying blood transfusion improved ROP outcome. Only 11 infants with a minimum hematocrit between 25% and 30% did not undergo transfusion, (one infant with stage 0 to 1 ROP, four infants with stage 2 ROP, and six infants with stage 3 to threshold ROP). All other infants received transfusion when they reached this level of anemia. DISCUSSION The relationship of anemia to ROP is difficult to study due to many factors affecting blood hemoglobin and hematocrit values, especially blood transfusions. Once an infant has received a blood transfusion, the anemia is temporarily resolved and hemoglobin/hematocrit values increase. This codependency was overcome in our study by separately analyzing hemoglobin/hematocrit values and number of blood transfusions each week of life during hospitalization. In addition, the decision to transfuse is affected by other variables, such as the presence of lung disease, oxygen status, and overall health of the infant. Data were analyzed using logistic regression to control for these confounding variables. We found only three other studies addressing anemia as a possible risk factor in ROP development. Bossi et al. 7 evaluated the association between anemia and ROP in infants weighing less than 1500 g. The medical records of 53 infants with ROP and 53 infants without ROP were analyzed, matching for EGA, birth weight, birth date, and hospitalization at the same neonatal unit. The mean blood hemoglobin values for the first 35 days of hospitalization were identical between the two groups. However, the frequency of blood transfusions was significantly different. Infants with ROP received transfusions whereas babies without ROP received transfusions ( p<0.01). A decade later, Alter et al. 23 found no difference between infants with stage 2ROP andinfants with stage 3 ROP when evaluating hemoglobin levels during the first week of life ( p=0.059)or number of blood transfusions ( p=0.072). A recent prospective study by Brooks et al. 20 found no association between anemia or blood transfusions and ROP incidence or severity in infants evaluated during a 6-week period (day of life 29 to 71). Of the 50 infants prospectively enrolled, only 34 infants completed the study. Sixteen infants in group 1 received blood transfusions only if certain medical criteria were met, maintaining average hematocrit levels at 33.9%. Eighteen infants in group 2 received blood transfusions to maintain hematocrit levels 40% (average 41.8% over 6 weeks). Despite large differences in anemia ( p=0.0001)and blood transfusions between the two groups (average 2.8 vs. 5.7 transfusions, p=0.0007), there was no difference in ROP incidence (83%vs. 73%,p=0.38)or ROP severity ( p=0.32). However, small sample size makes it difficult to draw clinically useful conclusions regarding ROP risk factors. 24 Other reports addressing an association between blood transfusions and ROP development without analyzing anemia had variable findings. Mittelman and Cronin 25 found that infants weighing less than 1360 g at birth who developed ROP received more blood transfusions but also more oxygen therapy. The ratio of transfusions to days of supplemental oxygen administration was actually greater in those infants without ROP than in those infants who developed 24 Journal of Perinatology 2001; 21:21 ± 26
5 Anemia and ROP Englert et al. ROP, which is opposite our results. Sacks et al. 21 found that infants weighing less than 1251 g with ROP received more replacement blood transfusions than infants without ROP by univariate analysis, but this association was not significant when controlling for oxygen therapy. Similar to our findings, Cooke et al. 26 found that only gestational age and frequency of blood transfusions were independently associated with development of ROP. They reported a significant difference in median frequency of blood transfusions between 92 infants weighing less than 1500 g without ROP and 92 infants with ROP (1 vs. 7 transfusions). They also found differences in median frequency of blood transfusions between infants with stage 1 to 3 ROP and infants with threshold disease (6 transfusions vs. 16 transfusions). Although the association of blood transfusions and ROP development has been shown in some studies, this does not prove a cause-and-effect relationship. However, there is speculation that transfusions containing adult hemoglobin with its lower affinity for oxygen than fetal hemoglobin F cause greater oxygen delivery to the retina, increasing the risk for developing ROP. 2 In addition, packed red blood cell transfusions contain large amounts of iron, which can rapidly increase serum iron levels in premature infants. Free iron can produce free radicals, which have been enzymatically linked to ROP development. 27,28 To test the hypothesis that increased iron load promotes the development of ROP, Inder et al. 29 performed a prospective study evaluating serum iron concentrations in infants with ROP and those without ROP who weighed less than 1250 g at birth. By 7 days of age, infants with ROP had significantly higher mean serum iron levels than infants without ROP. By 28 days of age, these values were no longer significantly different. However, total blood transfusion volume remained significantly different between the two groups at 7 and 28 days of age, suggesting no relationship between iron concentration and transfusion frequency. Hesse et al. 30 found that, although blood transfusions were an independent risk factor for ROP, the iron load did not appear to be associated with ROP development during the first 6 months of life in infants weighing less than 1500 g. CONCLUSION Our study is the first to assess duration of anemia as a risk factor for ROP by evaluating serial hemoglobin and hematocrit levels in extremely low birth weight infants. Anemia (Hgb10 g/dl or Hct30%)was not significantly associated with severity of ROP in this group of infants. Using univariate analysis, our data confirm known risk factors of gestational age, blood transfusions, ventilator days, male sex, and presence of bronchopulmonary dysplasia. Only EGA at birth and frequency of blood transfusions remained risk factors for ROP severity using logistic regression. Those children who remained severely anemic (Hgb8 g/dlorhct25%)for longer periods of time and received fewer transfusions were less likely to develop severe ROP. Our findings suggest that delaying blood transfusions in otherwise asymptomatic premature infants does not increase their risk of developing clinically significant ROP. References 1. Ben- Sira I, Nissenkorm I, Kremer I. Retinopathy of prematurity. Surv Ophthalmol 1988;33:1 ± Bossi E, Koerner F. Retinopathy of prematurity. Intensive Care Med 1995;21:241 ± Gilbert C, Rahi J, Eckstein M, et al. Retinopathy of prematurity in middleincome countries. Lancet 1997;350:12 ± Phelps DL. Retinopathy of prematurity: an estimate of vision loss in the United States Ð Pediatrics 1981;67:924 ± Brown DR, Biglan AW, Stretavsky MMA. Retinopathy of prematurity: the relationship with intraventricular hemorrhage and bronchopulmonary dysplasia. J Pediatr Ophthalmol Strabismus 1990;27:268 ± Steinkuller PG, Du L, Gilbert C, Foster A, Collins ML, Coats DK. Childhood blindness. J AAPOS 1999;3:26 ± Bossi E, Koerner F, Zulauf M. Retinopathy of prematurity: a risk factor analysis with univariate and multivariate statistics. Helv Paediatr Acta 1984;39:307 ± Gunn TR, Easdown J, Outerbridge EW, Aranda JV. Risk factors in retrolental firbroplasia. Pediatrics 1980;65:1096 ± Nodgaard H, Andreasen H, Hansen H, Sorensen HT. Risk factors associated with retinopathy of prematurity ( ROP)in Northern Jutland, Denmark 1990± Acta Ophthalmol Scand 1996;74:306 ± HolmstroÈm G, Broberger U, Thomassen P. Neonatal risk factors for retinopathy of prematurity Ð a population- based study. Acta Ophthalmol Scand 1998;76:204 ± Prendiville A, Schulenburg WE. Clinical factors associated with retinopathy of prematurity. Arch Dis Child 1988;63:522 ± Schaffer DB, Palmer EA, Plotsky DF, et al. Prognostic factors in the natural course of retinopathy of prematurity. Ophthalmology 1993;100:230 ± Purohit DM, Ellison RC, Zierler S, Miettinen OS, Nadas AS. Risk factors for retrolental fibroplasia with 3,025 premature infants. Pediatrics 1985;76:339± Gallo JE, Jacobson L, Broberger U. Perinatal factors associated with retinopathy of prematurity. Acta Paediatr 1993;82:829 ± Saunders RA, Donahue ML, Christmann LM, et al. Racial variation in retinopathy of prematurity. Arch Ophthalmol 1997;115:604 ± Biglan AW, Brown DR, Reynolds JD, Milley JR. Risk factors associated with retrolental fibroplasia. Ophthalmology 1984;91:1504 ± Chirico G, the Italian ROP Study Group. Italian multicentre study on retinopathy of prematurity. Eur J Pediatr 1997;156:939 ± Shahinian L, Malachowski N. Retrolental fibroplasia Ð a new analysis of risk factors based on recent cases. Arch Ophthalmol 1978;96:70 ± Shohat M, Reisner SH, Krikler R, Nissenkorn I, Yassur Y, Ben- Sira I. Retinopathy of prematurity: incidence and risk factors. Pediatrics 1983;72: 159± Brooks SE, Marcus DM, Gillis D, Pirie E, Johnson MH, Bhatia J. The effect of blood transfusion protocol on retinopathy of prematurity: a prospective, randomized study. Pediatrics 1999;104:514 ± Sacks LM, Schaffer DB, Anday EK, Peckham GJ, Delivoria- Papadopoulos M. Retrolental fibroplasia and blood transfusion in very low- birth- weight infants. Pediatrics 1981;68:770 ±74. Journal of Perinatology 2001; 21:21 ± 26 25
6 Englert et al. Anemia and ROP 22. Cryotherapy for retinopathy of prematurity cooperative group: Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results. Arch Ophthalmol 1988;106:471 ± 79. ( Identical publication in Pediatrics 1988;81: 697±706). 23. Alter D, Garcia-Valenzuela E, Kim Y, Kammer J, Viana M, Shapiro M. Hemoglobin levels, blood transfusions, and other neonatal risk factors associated with progression of retinopathy of prematurity. Invest Opthalmol Visual Sci 1998;39( Suppl 4):S Saunders RA, Purohit D, Hulsey TC. The effects of blood transfusion protocol on retinopathy of prematurity ( Letter to the Editor). Pediatrics. [In press]. 25. Mittelman D, Cronin C. The relationship of blood transfusions to retrolental fibroplasia. Ann Ophthalmol 1983;15:376 ± Cooke RWI, Clark D, Hickey-Dwyer M, Weindling AM. The apparent role of blood transfusions in the development of retinopathy of prematurity. Eur J Pediatr 1993;152:833 ± Sullivan JL. Iron, plasma antioxidants and the ``oxygen radical disease of prematurity.'' Am J Dis Child 1988;142:1341 ± Hittner HM, Rudolph AJ, Kretzer FL. Suppression of severe retinopathy of prematurity with vitamin E supplementation. Ophthalmology 1984;91: 1512± Inder TE, Clemett RS, Austin NC, Graham P, Darlow BA. High iron status in very low birth weight infants is associated with an increased risk of retinopathy of prematurity. J Pediatr 1997;131:541 ± Hesse L, Eberl W, Schlaud M, Poets CF. Blood transfusion Ð iron load and retinopathy of prematurity. Eur J Pediatr 1997;156:465 ± Journal of Perinatology 2001; 21:21 ± 26
Multicenter Study of Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) Publications
Multicenter Study of Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) Publications Bartholomew PA, Chao J, Evans JL, Hammel AM, Trueb AL, Verness JL, Dobson V, Quinn GE. Acceptance/Use of the Teller
More informationDistribution of Retinopathy of Prematurity and Its Risk Factors
Original Article Iran J Pediatr Jnu 2011; Vol 21 (No 2), Pp: 209-214 Distribution of Retinopathy of Prematurity and Its Risk Factors Amirkhosro Ghaseminejad *1, MD, and Pedram Niknafs 2, MD 1. Department
More informationINFANTS WITH birth weights less
CLINICAL SCIENCES of Retinopathy of Prematurity Michael X. Repka, MD; Earl A. Palmer, MD; Betty Tung, MS; for the Cryotherapy for Retinopathy of Prematurity Cooperative Group Objective: To report the timing
More informationIncidence and risk factors for retinopathy of prematurity in the West Black Sea region, Turkey
The Turkish Journal of Pediatrics 2012; 54: 113-118 Original Incidence and risk factors for retinopathy of prematurity in the West Black Sea region, Turkey Atilla Alpay, Suat Hayri Uğurbaş Department of
More informationRetinopathy of prematurity: A comprehensive risk analysis for prevention and prediction of disease
RESEARCH ARTICLE Retinopathy of prematurity: A comprehensive risk analysis for prevention and prediction of disease Leah A. Owen 1,2 *, Margaux A. Morrison 1,2, Robert O. Hoffman 1,2, Bradley A. Yoder
More informationCURRICULUM VITAE. (713) (O) B.S. in Biology, Fu-Jen Catholic University, Taiwan, R.O.C., 1974
CURRICULUM VITAE NAME: Betty P. Tung BIRTH DATE: November 23, 1951 OFFICE (713) 500-9549(O) Betty.p.tung@uth.tmc.edu EDUCATIONAL BACKGROUND: B.S. in Biology, Fu-Jen Catholic University, Taiwan, R.O.C.,
More informationRetinopathy of Prematurity. Objectives. Normal Retina Development. ROP Pathogenesis 6/8/2018. Thomas W. Hejkal, MD, PhD Eye Consultants, PC
Retinopathy of Prematurity Thomas W. Hejkal, MD, PhD Eye Consultants, PC Chair Emeritus Department of Ophthalmology UNMC drhejkal@eyeconsultantspc.com (No commercial interests) Objectives Identify risk
More informationRETINOPATHY OF PREMATUrity
CLINICAL SCIENCES Longitudinal Postnatal Weight Measurements for the Prediction of Retinopathy of Prematurity Carolyn Wu, MD; Deborah K. VanderVeen, MD; Ann Hellström, MD, PhD; Chatarina Löfqvist, PhD;
More informationA pilot randomised controlled trial of peripheral fractional oxygen extraction to guide blood transfusions in preterm infants. tissues.
F22 ORIGINAL ARTICLE A pilot randomised controlled trial of peripheral fractional oxygen extraction to guide blood transfusions in preterm infants S P Wardle, R Garr, C W Yoxall, A M Weindling... See end
More informationNon-ophthalmologist screening for retinopathy of prematurity
130 Br J Ophthalmol 2000;84:130 134 ORIGINAL ARTICLES Clinical science N Edgar Miles Center for Pediatric Ophthalmology, Storm Eye Institute, Medical University of South Carolina, Charleston, South Carolina
More informationR etinopathy of prematurity (ROP), a condition confined
F240 ORIGINAL ARTICLE UK population based study of severe retinopathy of prematurity: screening, treatment, and outcome L Haines, A R Fielder, H Baker, A R Wilkinson... See end of article for authors affiliations...
More informationIncidence and Risk Factors for Retinopathy of Prematurity in Very Low Birth Weight Infants in Kermanshah, Iran
World Applied Sciences Journal 18 (5): 600-604, 2012 ISSN 1818-4952 IDOSI Publications, 2012 DOI: 10.5829/idosi.wasj.2012.18.05.1562 Incidence and Risk Factors for Retinopathy of Prematurity in Very Low
More informationRisk Factors for Retinopathy of Prematurity in Extremely Preterm Chinese Infants
Risk Factors for Retinopathy of Prematurity in Extremely Preterm Chinese Infants Gordon S.K. Yau, FRCSEd, Jacky W.Y. Lee, FRCSEd, Victor T.Y. Tam, FCOphthHK, Catherine C.L. Liu, PhD, and Ian Y.H. Wong,
More informationCriteria for the timing of the initial retinal examination to screen for retinopathy of prematurity
VOL. 35 NO. PHILIPPINE JOURNAL OF Ophthalmology JANUARY ORIGINAL ARTICLE JUNE 00 Milagros H. Arroyo, MD, MPH - Dino L. Camonias, MD Andrea Kristina Monzon-Pajarillo, MD Farlah Angela M. Salvosa-Sevilla,
More informationAdjusted poor weight gain for birth weight and gestational age as a predictor of severe ROP in VLBW infants
(2011) 25, 725 729 & 2011 Macmillan Publishers Limited All rights reserved 0950-222X/11 www.nature.com/eye Adjusted poor weight gain for birth weight and gestational age as a predictor of severe ROP in
More informationDownloaded from journal.gums.ac.ir at 15:41 IRST on Friday February 22nd 2019
1 * 3 2 1 - (MD) - (PhD Candidate) - (MD) - 4 1 (MD) - (MD) * : reza_sm76@yahoo.com : 94/05/12 : 94/02/13 (MD) 93/11/07:. :. : :. 1389 (%51/3) 40. (% 78/8) 78 : (%9) 7. (%48/7) 38. 2 (%10/3) 8 2 (%9) 7
More informationUniversal Newborn Eye Screening
Universal Newborn Eye Screening Nil financial disclosure Samantha Simkin Paediatric visual impairment 19 million children worldwide are visually impaired 1 1.4 million children are blind 1 Social, economic
More informationTransfusion & Mortality. Philippe Van der Linden MD, PhD
Transfusion & Mortality Philippe Van der Linden MD, PhD Conflict of Interest Disclosure In the past 5 years, I have received honoraria or travel support for consulting or lecturing from the following companies:
More informationResearch Article Timing of Caffeine Therapy and Neonatal Outcomes in Preterm Infants: A Retrospective Study
International Pediatrics Volume 2016, Article ID 9478204, 6 pages http://dx.doi.org/10.1155/2016/9478204 Research Article Timing of Caffeine Therapy and Neonatal Outcomes in Preterm Infants: A Retrospective
More informationArchive of SID. Downloaded from jmums.mazums.ac.ir at 2: on Monday October 8th
1380 مريم نخشب(. M.D )* قاسم بياني(. M.D )** محمد اسحاقي تيموري(. M.D )*** چكيده سابقه و هدف احمد احمدزاده اميري(. M.D )*** ROP (Retinopathy Of Prematurity) :.. مواد و روش ها : -. ( ) /.. يافتهها : ROP
More informationStudy of Incidence, Clinical Staging and Risk Factors of Retinopathy of Prematurity in Rural Area
Original Article Study of Incidence, Clinical Staging and Risk Factors of Retinopathy of Prematurity in Rural Area Neeraj Gupta, Narendra P Datti, *Beeregowda Y, Kanthamani Krishnappa, Krishnamurthy D
More informationComparison of Two Phototherapy Methods (Prophylactic vs Therapeutic) for Management of Hyperbilirubinemia in Very Low Birth Weight Newborns
Original Article Iran J Pediatr Dec 2011; Vol 21 (No 4), Pp: 425-430 Comparison of Two Phototherapy Methods (Prophylactic vs Therapeutic) for Management of Hyperbilirubinemia in Very Low Birth Weight Newborns
More informationRetinopathy of Prematurity: A Visually Impairing Disorder Name English 12 Section 35 Professor Marchbanks September 29, 2005
Retinopathy of Prematurity: A Visually Impairing Disorder Name English 12 Section 35 Professor Marchbanks September 29, 2005 1 Retinopathy of prematurity (ROP) is a visually impairing disorder which occurs
More informationHypothermia at Birth and its Associated Complications in Newborns: a Follow up Study
Iranian J Publ Health, 2006, Vol. 35, No. Iranian 1, pp.48-52 J Publ Health, 2006, Vol. 35, No. 1, pp.48-52 Hypothermia at Birth and its Associated Complications in Newborns: a Follow up Study *F Nayeri,
More informationPulsed mode versus near-continuous mode delivery of diode laser photocoagulation for high-risk retinopathy of prematurity
Pulsed mode versus near-continuous mode delivery of diode laser photocoagulation for high-risk retinopathy of prematurity Evelyn A. Paysse, MD, a,b Mohamed A.W. Hussein, MD, a Aaron M. Miller, MD, a Kathryn
More informationROLE OF EARLY POSTNATAL DEXAMETHASONE IN RESPIRATORY DISTRESS SYNDROME
INDIAN PEDIATRICS VOLUME 35-FEBRUAKY 1998 ROLE OF EARLY POSTNATAL DEXAMETHASONE IN RESPIRATORY DISTRESS SYNDROME Kanya Mukhopadhyay, Praveen Kumar and Anil Narang From the Division of Neonatology, Department
More informationGS3. Understanding How to Use Statistics to Evaluate an Article. Session Summary. Session Objectives. References. Session Outline
GS3 Understanding How to Use Statistics to Evaluate an Article Reese H. Clark, MD Director of Research Pediatrix Medical Group Neonatologist Greenville Memorial Hospital, Greenville, SC The speaker has
More informationClinicoetiological profile and risk assessment of newborn with respiratory distress in a tertiary care centre in South India
International Journal of Contemporary Pediatrics Sahoo MR et al. Int J Contemp Pediatr. 2015 Nov;2(4):433-439 http://www.ijpediatrics.com pissn 2349-3283 eissn 2349-3291 Research Article DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20150990
More informationPATENT DUCTUS ARTERIOSUS IN THE PRETERM INFANT EVIDENCE FOR & AGAINST TREATMENT
PATENT DUCTUS ARTERIOSUS IN THE PRETERM INFANT EVIDENCE FOR & AGAINST TREATMENT Dr. Youssef Abou Zanouna, FRCPI, FACC Consultant Pediatric Cardiologist King Fahd Military Medical Complex Dhahran Introduction
More informationCumulative illness severity and progression from moderate to severe retinopathy of prematurity
(2007) 27, 502 509 r 2007 Nature Publishing Group All rights reserved. 0743-8346/07 $30 www.nature.com/jp ORIGINAL ARTICLE Cumulative illness severity and progression from moderate to severe retinopathy
More informationPeri-Operative Management: Guidelines for Inpatient Management of Children with Sickle Cell Disease
Version 02 Approved by Interprofessional Patient Care Committee: September 16, 2016 1.0 Background Children with Sickle Cell are at risk of developing post-operative Acute Chest Syndrome. With improvements
More informationResearch Roundtable Summary
Research Roundtable Summary 10 TENTH in a Series of Seminars on MCHB-funded Research Projects Early Cortisol Deficiency and Bronchopulmonary Dysplasia October 18, 1995 Parklawn Building Potomac Conference
More informationRed blood cell transfusions in the PICU: What & When
Red blood cell transfusions in the PICU: What & When Canada Critical Care Forum November 8th 2018 Toronto, CA Marisa Tucci and Jacques Lacroix Pediatric Intensive Care Sainte-Justine University Hospital
More informationRetinopathy of prematurity (ROP) is a disorder of retinal
INVITED COMMENTARY Retinopathy of Prematurity Alice L. Bashinsky Retinopathy of prematurity (ROP) is a vasoproliferative retinal disorder unique to premature infants. As premature births increase in many
More informationScreening Examination of Premature Infants for Retinopathy of Prematurity
Screening Examination of Premature Infants for Retinopathy of Prematurity (1) Overview material Release Date 2006 Status Available in Electronic Format Available in Print Format Bibliographic citation
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/46692 holds various files of this Leiden University dissertation Author: Zanten, Henriëtte van Title: Oxygen titration and compliance with targeting oxygen
More informationUsing Nightingale to Identify Opportunities for Improvement
Using Nightingale to Identify Opportunities for Improvement Erika M. Edwards PhD, MPH Director of Data Systems and Analytics Vermont Oxford Network Research Assistant Professor Mathematics and Statistics
More informationThe New England Journal of Medicine LACK OF EFFICACY OF LIGHT REDUCTION IN PREVENTING RETINOPATHY OF PREMATURITY
LACK OF EFFICACY OF LIGHT REDUCTION IN PREVENTING RETINOPATHY OF PREMATURITY JAMES D. REYNOLDS, M.D., ROBERT J. HARDY, PH.D., KATHLEEN A. KENNEDY, M.D., RAND SPENCER, M.D., W.A.J. VAN HEUVEN, M.D., AND
More informationCORD BLOOD TESTING AND HDFN A CASE STUDY. Eric Rosa, MLS (ASCP) CM University of Kansas Hospital April 20, 2016
CORD BLOOD TESTING AND HDFN A CASE STUDY Eric Rosa, MLS (ASCP) CM University of Kansas Hospital April 20, 2016 BACKGROUND KU Hospital policy: run ABO/Rh (front) type + Direct Antiglobulin test on cord
More informationAdvanced Necrotizing Enterocolitis Part 1: Mortality
8 Original Article Advanced Necrotizing Enterocolitis Part 1: Mortality M. Thyoka 1 P. de Coppi 1 S. Eaton 1 K. Khoo 1 N.J. Hall 1 J. Curry 1 E. Kiely 1 D. Drake 1 K. Cross 1 A. Pierro 1 1 Department of
More informationLong term follow up of premature infants: detection of strabismus, amblyopia, and refractive errors
Br J Ophthalmol 2000;84:963 967 963 FC Donders Institute of Ophthalmology, University Hospital, Utrecht, N E Schalij-Delfos MELdeGraaf WFTreVers Centre for Quantitative Methods, Eindhoven, J Engel Department
More informationBy: Armend Lokku Supervisor: Dr. Lucia Mirea. Maternal-Infant Care Research Center, Mount Sinai Hospital
By: Armend Lokku Supervisor: Dr. Lucia Mirea Maternal-Infant Care Research Center, Mount Sinai Hospital Background My practicum placement was at the Maternal-Infant Care Research Center (MiCare) at Mount
More informationDe.3 If included in a composite, please identify the composite measure (title and NQF number if endorsed): N/A
NATIONAL QUALITY FORUM Measure Submission and Evaluation Worksheet 5.0 This form contains the information submitted by measure developers/stewards, organized according to NQF s measure evaluation criteria
More informationAntidepressant Use and Depressive Symptoms in Intensive Care Unit Survivors
Antidepressant Use in ICU Survivors 1 Antidepressant Use and Depressive Symptoms in Intensive Care Unit Survivors Sophia Wang, MD, Chris Mosher, MD, Sujuan Gao, PhD, Kayla Kirk, MA, Sue Lasiter, PhD, RN,
More informationReviews in Clinical Medicine
Mashhad University of Medical Sciences (MUMS) Reviews in Clinical Medicine Clinical Research Development Center Ghaem Hospital The relation between oxygen saturation level and retionopathy of prematurity
More informationBlood transfusion and intestinal perfusion in preterm infants Narendra Aladangady
Blood transfusion and intestinal perfusion in preterm infants Narendra Aladangady MD, FRCPCH, PhD Consultant Neonatologist Hon Clinical Professor in Child Health History of blood transfusion First report
More informationVisual Impairment & Eye Health in Children. Susan Cotter, OD, MS So CA College of Optometry Marshall B Ketchum University Fullerton, CA
Visual Impairment & Eye Health in Children Susan Cotter, OD, MS So CA College of Optometry Marshall B Ketchum University Fullerton, CA Consequences of Childhood VI Social Emotional Physical Educational
More informationPatent Ductus Arteriosus: Philosophy or Pathology?
Patent Ductus Arteriosus: Philosophy or Pathology? Disclosure Ray Sato, MD is a speaker for Prolacta Biosciences, Inc. This presentation will discuss off-label uses of acetaminophen and ibuprofen. RAY
More informationFINAL RESULTS OF THE EARLY TREATMENT FOR RETINOPATHY OF PREMATURITY (ETROP) RANDOMIZED TRIAL
FINAL RESULTS OF THE EARLY TREATMENT FOR RETINOPATHY OF PREMATURITY (ETROP) RANDOMIZED TRIAL BY William V. Good MD,* on behalf of the Early Treatment for Retinopathy of Prematurity Cooperative Group ABSTRACT
More informationScreening of Retinopathy of Prematurity in City, Sudan,
Merit Research Journal of Microbiology and Biological Sciences Vol. 2(2) pp. 025-030, March, 2014 Available online http://www.meritresearchjournals.org/mbs/index.htm Copyright 2014 Merit Research Journals
More informationSAMPLE. V.12.1 Special Report: Very Low Birthweight Neonates. I. Introduction
I. Introduction V.12.1 Special Report: Very Low Birthweight Neonates The delivery of a very low birth weight infant continues to present many challenges to families and health care providers in spite of
More informationNoah Hillman M.D. IPOKRaTES Conference Guadalajaira, Mexico August 23, 2018
Postnatal Steroids Use for Bronchopulmonary Dysplasia in 2018 + = Noah Hillman M.D. IPOKRaTES Conference Guadalajaira, Mexico August 23, 2018 AAP Policy Statement - 2002 This statement is intended for
More informationRango de saturacion de oxigeno: Cual es la evidencia?
Rango de saturacion de oxigeno: Cual es la evidencia? Wally Carlo, M.D. University of Alabama at Birmingham Department of Pediatrics Division of Neonatology wcarlo@peds.uab.edu 1 2 Stevie Wonder 4 Objectives
More informationOverview. Retinal vascularisation during development. Classification of ROP. Visual loss from retinopathy of prematurity: first global estimates
Visual loss from retinopathy of prematurity: first global estimates Overview ROP - the condition, risk factors and control ROP as a cause of visual loss Earlier estimates New global estimates MARCH seminar,
More informationRecommendations for Hospital Quality Measures in 2011:
Pediatric Measures: Recommendations for Hospital Quality Measures in 2011: Based on the input of a group of healthcare stakeholders, the following new hospital measures are recommended: 1) Home Management
More informationARTIFICIAL INTELLIGENCE FOR PREDICTION OF SEPSIS IN VERY LOW BIRTH WEIGHT INFANTS
ARTIFICIAL INTELLIGENCE FOR PREDICTION OF SEPSIS IN VERY LOW BIRTH WEIGHT INFANTS Markus Leskinen MD PhD, Neonatologist Children s Hospital, University of Helsinki and Helsinki University Hospital The
More informationCircumcision bleeding complications: Neonatal intensive care infants compared to. those in the normal newborn nursery
Circumcision bleeding complications: Neonatal intensive care infants compared to those in the normal newborn nursery Abigail R. Litwiller MD 1, David M. Haas MD, MS 2 1 Department of OB/GYN, University
More informationRetinopathy of prematurity: clinical aspects
Semin Neonatol 2001; 6: 461 475 doi:10.1053/siny.2001.0091, available online at http://www.idealibrary.com on Retinopathy of prematurity: clinical aspects Alistair R. Fielder a and James D. Reynolds b
More informationSupplementary Online Content
Supplementary Online Content Dhabangi A, Ainomugisha B, Cserti-Gazdewich C, et al. Effect of transfusion of red blood cells with longer vs shorter storage duration on elevated blood lactate levels in children
More informationQueen Charlotte Hospital
Queen Charlotte Hospital Neuroprotection for neonatal encephalopathy Neonatal encephalopathy accounts for 1 million deaths worldwide and even greater numbers of disabled survivors In countries with
More informationChildhood blindness due to ROP
Childhood blindness due to ROP Number of blind children/10 million pop, by cause and level of development Proportion of blindness due to ROP, by World Bank region Estimates of numbers blind from ROP, by
More informationBONE MARROW PERIPHERAL BLOOD Erythrocyte
None Disclaimer Objectives Define anemia Classify anemia according to pathogenesis & clinical significance Understand Red cell indices Relate the red cell indices with type of anemia Interpret CBC to approach
More informationSupplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), A Randomized, Controlled Trial. I: Primary Outcomes
PEDIATRICS Feb 2000 VOL. 105 NO. 2 Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), A Randomized, Controlled Trial. I: Primary Outcomes The STOP-ROP Multicenter Study
More informationCord blood bilirubin used as an early predictor of hyperbilirubinemia
International Journal of Contemporary Pediatrics Ramamoorthy K et al. Int J Contemp Pediatr. 218 Jul;5(4):128-1285 http://www.ijpediatrics.com pissn 2349-3283 eissn 2349-3291 Original Research Article
More informationMaternal And Fetal Outcome In Pregnancies Complicated With Maternal Cardiac Diseases: Experience At A Tertiary Care Hospital
ISPUB.COM The Internet Journal of Gynecology and Obstetrics Volume 19 Number 1 Maternal And Fetal Outcome In Pregnancies Complicated With Maternal Cardiac Diseases: Experience At A Tertiary Care Hospital
More informationUSE OF INHALED NITRIC OXIDE IN THE NICU East Bay Newborn Specialists Guideline Prepared by P Joe, G Dudell, A D Harlingue Revised 7/9/2014
USE OF INHALED NITRIC OXIDE IN THE NICU East Bay Newborn Specialists Guideline Prepared by P Joe, G Dudell, A D Harlingue Revised 7/9/2014 ino for Late Preterm and Term Infants with Severe PPHN Background:
More informationMidterm Exam ANSWERS Categorical Data Analysis, CHL5407H
Midterm Exam ANSWERS Categorical Data Analysis, CHL5407H 1. Data from a survey of women s attitudes towards mammography are provided in Table 1. Women were classified by their experience with mammography
More informationShort-Term Outcome Of Different Treatment Modalities Of Patent Ductus Arteriosus In Preterm Infants. Five Years Experiences In Qatar
ISPUB.COM The Internet Journal of Cardiovascular Research Volume 7 Number 2 Short-Term Outcome Of Different Treatment Modalities Of Patent Ductus Arteriosus In Preterm Infants. Five Years Experiences In
More informationIncidence, Risk Factors of Retinopathy of Prematurity Among Very Low Birth Weight Infants in Singapore
Incidence, Risk Factors of ROP Among VLBW Infants VA Shah et al 169 Incidence, Risk Factors of Retinopathy of Prematurity Among Very Low Birth Weight Infants in Singapore VA Shah, 1 MD (Paeds), FAMS, MRCP
More informationEarly-goal-directed therapy and protocolised treatment in septic shock
CAT reviews Early-goal-directed therapy and protocolised treatment in septic shock Journal of the Intensive Care Society 2015, Vol. 16(2) 164 168! The Intensive Care Society 2014 Reprints and permissions:
More informationThe SUPPORT, BOOST II, and COT Trials You Must Understand Usual Care To Safeguard Patients and Make Firm Conclusions
The, BOOST II, and COT Trials You Must Understand Usual Care To Safeguard Patients and Make Firm Conclusions Charles Natanson M.D. Critical Care Medicine Department Clinical Center National Institutes
More informationArchives of Clinical and Biomedical Research
Archives of Clinical and Biomedical Research Volume 1, Issue 4 Research Article ISSN: 2572-5017 Haemoglobin Profiles of University Students Participating in Routine Medical Examinations, 2009-2011 Fabian
More informationFANNP 28TH NATIONAL NNP SYMPOSIUM: CLINICAL UPDATE AND REVIEW OCTOBER 17-21, 2017
Pulse Oximetry in the Delivery Room: Principles and Practice GS2 3 Jonathan P. Mintzer, MD, FAAP Assistant Professor of Pediatrics Stony Brook Children s Hospital, Division of Neonatal-Perinatal Medicine,
More informationLaser Therapy Versus Anti-VEGF Agents for Treatment of Retinopathy of Prematurity. Ilya Leskov, MD, PhD Shizuo Mukai, MD
Laser Therapy Versus Anti-VEGF Agents for Treatment of Retinopathy of Prematurity Ilya Leskov, MD, PhD Shizuo Mukai, MD Introduction Retinopathy of prematurity (ROP) is characterized by abnormal retinal
More informationMorris A. Blajchman, MD, FRCP(C) Emeritus Professor, McMaster University Hamilton, Ontario, CANADA
Morris A. Blajchman, MD, FRCP(C) Emeritus Professor, McMaster University Hamilton, Ontario, CANADA RBC TRANSFUSIONS: GENERAL PRINCIPLES RBCs are usually dispensed on a first-in, first-out basis. Storage
More informationPre-eclampsia and HIV. Matjies river. David Hall Department of O&G Stellenbosch University
Pre-eclampsia and HIV Matjies river David Hall Department of O&G Stellenbosch University Background HIV + hypertensive diseases - important conditions Both related to maternal and perinatal morbidity and
More informationDownloaded from armaghanj.yums.ac.ir at 20: on Friday March 22nd 2019 : * **
: :... :.... SPSS : / ± / / ± / / ± /.( p< /) / ± / / ±.( p< /).( p< /) / ±/ * ** * ** / / : / /: : drhesamnabavi@yahoo.com: :. : ..( ).... 1-Glucose 6- Phosphate Dehydrogenase (G6PD) 2-Combs Test....(
More informationRisk factors associated with retinopathy of prematurity among neonates in a tertiary care hospital in Nepal
Original Article Journal of Kathmandu Medical College, Vol. 5, No. 1, Issue 15, Jan.-Mar., 2016 Risk factors associated with retinopathy of prematurity among neonates in a tertiary care hospital in Nepal
More informationSafe and Healthy Beginnings. M. Jeffrey Maisels MD William Beaumont Hospital Royal Oak, MI
Safe and Healthy Beginnings M. Jeffrey Maisels MD William Beaumont Hospital Royal Oak, MI jmaisels@beaumont.edu Risk Factors There are 2 kinds Those that increase the risk of subsequently developing a
More informationPediatric Cardiology. Spontaneous Closure of Atrial Septal Defects in Premature vs Full-Term Neonates
Pediatr Cardiol 21:129 134, 2000 DOI: 10.1007/s002469910020 Pediatric Cardiology Springer-Verlag New York Inc. 2000 Spontaneous Closure of Atrial Septal Defects in Premature vs Full-Term Neonates T. Riggs,
More informationReceived: Jun 15, 2013; Accepted: Nov 08, 2013; First Online Available: Jan 24, 2014
Original Article Iran J Pediatr Feb 2014; Vol 24 (No 1), Pp: 57-63 Management of Neonatal Respiratory Distress Syndrome Employing ACoRN Respiratory Sequence Protocol versus Early Nasal Continuous Positive
More informationAcute glomerulonephritis (AGN) is a
Original Article Paediatrica Indonesiana VOLUME 56 May 2016 Number 3 Prognostic factors for mortality in pediatric acute poststreptococcal glomerulonephritis Syamsul Nur, Husein Albar, Dasril Daud Abstract
More informationUpdate on mangement of patent ductus arteriosus in preterm infants. Dr. Trinh Thi Thu Ha
Update on mangement of patent ductus arteriosus in preterm infants Dr. Trinh Thi Thu Ha Outline 1. Overview of PDA 2. Timing of screening PDA? 3. When to treat PDA? Timing of ductal closure Prenatal
More informationClinical characteristics of febrile seizures and risk factors of its recurrence in Chiang Mai University Hospital
Neurology Asia 2017; 22(3) : 203 208 Clinical characteristics of febrile seizures and risk factors of its recurrence in Chiang Mai University Hospital Worawit Kantamalee MD, Kamornwan Katanyuwong MD, Orawan
More informationfirst three years of life
Journal of Epidemiology and Community Health, 1981, 35, 18-184 Parental smoking and lower respiratory illness in the first three years of life D. M. FERGUSSON, L. J. HORWOOD, F. T. SHANNON, AND BRENT TAYLOR
More informationThe influence of gestational age on the dynamic behavior of other risk factors associated with retinopathy of prematurity (ROP)
Graefes Arch Clin Exp Ophthalmol (2010) 248:893 900 DOI 10.1007/s00417-009-1248-6 PEDIATRICS The influence of gestational age on the dynamic behavior of other risk factors associated with retinopathy of
More informationMAKING THE NSQIP PARTICIPANT USE DATA FILE (PUF) WORK FOR YOU
MAKING THE NSQIP PARTICIPANT USE DATA FILE (PUF) WORK FOR YOU Hani Tamim, PhD Clinical Research Institute Department of Internal Medicine American University of Beirut Medical Center Beirut - Lebanon Participant
More informationPCMCH ROP Screening Guidelines
PCMCH ROP Screening Guidelines An expert panel convened by PCMCH (the ROP Work Group) recommends the Canadian Paediatric Society s 2010 guidelines be adopted as Ontario s screening guidelines for ROP.
More informationEmilia Parodi, 1 Maria Teresa Giraudo, 2 Fulvio Ricceri, 3 Maria Luigia Aurucci, 4 Raffaela Mazzone, 5 and Ugo Ramenghi 4. 1.
Anemia Volume 2016, Article ID 7345835, 6 pages http://dx.doi.org/10.1155/2016/7345835 Research Article Absolute Reticulocyte Count and Reticulocyte Hemoglobin Content as Predictors of Early Response to
More informationFactors Influencing the Prevalence of Amblyopia in Children with Anisometropia
pissn: 1011-8942 eissn: 2092-9382 Korean J Ophthalmol 2010;24(4):225-229 DOI: 10.3341/kjo.2010.24.4.225 Factors Influencing the Prevalence of Amblyopia in Children with Anisometropia Original Article Chong
More informationEVIDENCE BASED RED CELL TRANSFUSION. Rana Samuel, MD DIRECTOR, PATHOLOGY AND LABORATORY MEDICINE VA WNY Health Care System
EVIDENCE BASED RED CELL TRANSFUSION Rana Samuel, MD DIRECTOR, PATHOLOGY AND LABORATORY MEDICINE VA WNY Health Care System HISTORY Blood transfusion works (ie: red cell transfusion saves lives). based on
More informationLONG-TERM VISUAL OUTCOMES IN EXTREMELY LOW-BIRTH-WEIGHT CHILDREN (AN AMERICAN OPHTHALMOLOGICAL SOCIETY THESIS)
LONG-TERM VISUAL OUTCOMES IN EXTREMELY LOW-BIRTH-WEIGHT CHILDREN (AN AMERICAN OPHTHALMOLOGICAL SOCIETY THESIS) BY Rand Spencer MD ABSTRACT Purpose: The goal is to analyze the long-term visual outcome of
More informationExploring the Relationship Between Substance Abuse and Dependence Disorders and Discharge Status: Results and Implications
MWSUG 2017 - Paper DG02 Exploring the Relationship Between Substance Abuse and Dependence Disorders and Discharge Status: Results and Implications ABSTRACT Deanna Naomi Schreiber-Gregory, Henry M Jackson
More informationEvaluating the Cryotherapy for Retinopathy of Prematurity Study (CRYO-ROP) (REPRINTED) ARCH OPHTHALMOL / VOL 125 (NO.
Cryotherapy proved to be far less successful in zone 1 disease than in zone 2 disease, where fortunately greater than 75% of the disease occurs. It is important to note that unfavorable outcomes as stage
More informationClassification of ROP
Classification of ROP Thomas Lee 2 Keywords Retinopathy of prematurity (ROP) Threshold ROP Plus disease Neovascularization Avascular retina Retinopathy of prematurity (ROP) is an iatrogenic disease. Prior
More informationClinical Study Incidence of Retinopathy of Prematurity in Extremely Premature Infants
ISRN Pediatrics, Article ID 134347, 4 pages http://dx.doi.org/10.1155/2014/134347 Clinical Study Incidence of Retinopathy of Prematurity in Extremely Premature Infants Alparslan Fahin, Muhammed Fahin,
More informationSubgroup Analysis of the MARINA Study of Ranibizumab in Neovascular Age-Related Macular Degeneration
Subgroup Analysis of the MARINA Study of in Neovascular Age-Related Macular Degeneration David S. Boyer, MD, 1 Andrew N. Antoszyk, MD, 2 Carl C. Awh, MD, 3 Robert B. Bhisitkul, MD, PhD, 4 Howard Shapiro,
More informationCorrelation between the levels of anti- A/B IgM/IgG antibodies and cord blood bilirubin levels in haemolytic disease of the new-born
Original article Correlation between the levels anti- A/B IgM/IgG antibodies and cord blood bilirubin levels in haemolytic disease the new-born C HEMACHANDRIKA 1* TK SHAANTHI GUNASINGH 2 1Pressor & Head,
More informationSenior Vice President, Medical Affairs and Health Outcomes, 150 South Saunders Road, Lake Forest, IL 60045, Horizon Pharma USA, Inc, USA
Research Hyperammonemic crises in patients with urea cycle disorders on chronic nitrogen scavenger therapy with either sodium phenylbutyrate or glycerol phenylbutyrate Jeffrey D Kent 1, Robert J Holt,2
More informationPEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)
PEER REVIEW HISTORY BMJ Paediatrics Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form and are provided with free text boxes to elaborate
More information